Pin1 drives pro-connective tissue proliferation and immunosuppressive TME and promotes tumor malignancy and drug resistance by acting on stromal cells such as CAF and by acting on pS929-HIP1R to induce endocytosis and degradation of PD-L1 and ENT1 in cancer cells. This evidence concerns the gene PIN1 and cancer.